Finding New Ways to Treat Resistant Lymphoma

Finding new ways to treat resistant lymphoma

MD Anderson
Houston, TX Dr. Michelle Fanale

The National Stem Cell Foundation funded a 12-person clinical trial conducted by Dr. Michelle Fanale at the MD Anderson Cancer Center to test a multi-drug therapy option for patients with resistant lymphoma. The 4 patients with resistant  T-cell lymphoma in the trial had remarkable outcomes – one participant became cancer free and all three of the other participants with resistant T-cell lymphoma responded to treatment. The data has been presented at two  ASH (American Society of Hematology) Annual Meetings, a T-cell lymphoma forum meeting and a T-cell meeting in Bologna. The data is expected to be published in 2018.